GGrantIndex
Sort

16,179 grants matching malaria

Larval Ecology of Invasive Anopheles stephensi in Ethiopia

$198,490
Guofa Zhou · University Of California-Irvine · R21 · FY2024 · AI

(PQ9) Prevention of Bleomycin-induced Pulmonary Toxicity by Dichloroacetate (DCA)

$198,485
Jung-Whan Kim · University Of Texas Dallas · R21 · FY2016 · CA

Primary and Secondary Effects of Mass Antibiotic Distributions for Trachoma

$198,456
Bruce D. Gaynor · University Of California, San Francisco · K23 · FY2011 · EY

Geographic origins and dispersal of drug-resistant M. tuberculosis in South Africa: Advancing strategies for early detection

$198,421
Tyler Steven Brown · Massachusetts General Hospital · K08 · FY2022 · AI

Clinical Pharmacology of Malaria Control and Elimination: Pharmacodynamics ofArtemisinin-based Combination Agents and their Barriers to Drug Resistance

$198,400
Matthew Michael Ippolito · Johns Hopkins University · K23 · FY2020 · AI

The Immunologic Impact of In Utero Malaria Exposure and Prenatal Chemoprevention

$198,219
Mary Prahl · University Of California, San Francisco · K23 · FY2017 · AI

Identifying gaps between LLIN use and vector exposure to improve malaria control

$198,218
Paul Joseph Krezanoski · University Of California, San Francisco · K23 · FY2019 · AI

Towards molecular mechanisms of invertebrate Gustatory Receptors

$198,188
Paul A Garrity · Brandeis University · R21 · FY2021 · DC

Endemic Infectious Diseases of the Peruvian Amazon

$198,154
Joseph M. Vinetz · University Of California, San Diego · D43 · FY2011 · TW

Endemic Infectious Diseases of the Peruvian Amazon

$198,154
Joseph M. Vinetz · University Of California, San Diego · D43 · FY2010 · TW

Endemic Infectious Diseases of the Peruvian Amazon

$198,154
Joseph M. Vinetz · University Of California, San Diego · D43 · FY2009 · TW

Endemic Infectious Diseases of the Peruvian Amazon

$198,154
Joseph M. Vinetz · University Of California, San Diego · D43 · FY2012 · TW

Functional analysis of Plasmodium vivax drug resistance polymorphisms

$198,125
Manoj T Duraisingh · Harvard School Of Public Health · R21 · FY2017 · AI

Identification of diagnostic and prognostic host biomarkers of Zika virus infection by transcriptome profiling

$198,125
Charles Yen Chiu · University Of California, San Francisco · R21 · FY2017 · AI

Sex separation through targeting of conserved female-specific lethal genes in disease vector mosquitoes

$198,125
Molly Duman Scheel · Indiana University Indianapolis · R21 · FY2022 · AI

Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing

$198,125
Charles Yen Chiu · University Of California, San Francisco · R21 · FY2016 · AI

Fever Etiology and Prognostic Point-of-Care Biomarkers in African Children with Severe Febrile Illness

$198,098
Teresa Kortz · University Of California, San Francisco · K23 · FY2020 · AI

Memory T follicular helper cell kinetics and localization during recall immune responses to tetanus vaccination

$198,091
Anne Elizabeth Parker Frosch · Hennepin Healthcare Research Institute · K08 · FY2020 · AI

ANTIMALARIAL ACTIVITY OF TS INHIBITORS

$198,089
Pradipsinh K. Rathod · University Of Washington · P01 · FY2008 · AI

Plasmodium Falciparum Infection and Interference with Effective B Cell Memory

$198,073
Bryan R Greenhouse · University Of California, San Francisco · R21 · FY2015 · AI

Training Program in Molecular, Cell, and Development Biology

$198,066
Douglas R. Kellogg · University Of California Santa Cruz · T32 · FY2009 · GM

HIV Infection, Placental Inflammation, and Early Childhood Outcomes in HIV-exposed, Uninfected Infants in Uganda

$198,041
Lisa M Bebell · Massachusetts General Hospital · K23 · FY2021 · AI

Chemical characterization of SUMO specific proteases in Plasmodium falciparum

$198,000
Matthew S Bogyo · Stanford University · R21 · FY2011 · AI

Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization - Clinical Core

$198,000
Margaret Juliana McElrath · Seattle Children'S Hospital · U19 · FY2024 · AI

Identification of bacterial strains for development of an oral probiotic aimed at increasing nitric oxide bioavailability

$197,783
Daniel B Kim-Shapiro · Wake Forest University · R21 · FY2023 · DE